logo-loader
view88 Energy Ltd

88 Energy Limited raised A$6.75mln

The new cash injection will be used to bankroll the additional costs of the Charlie-1 well over and above the expenditure being carried by its partner, Premier Oil

88 Energy Ltd -

88 Energy Limited (ASX:88E, LON:88E) said it had raised A$6.75mln to fund ongoing work in Alaska.

Specifically, the new cash injection will be used to bankroll the additional costs of the Charlie-1 well over and above the expenditure being carried by its partner, Premier Oil (LON:PMO).

“Drilling Charlie-1 will be a pivotal moment for the Company as it seeks to unlock the large potential of the conventional plays on the acreage,” said managing director Dave Wall.

The additional monies will also go towards lease rental payments due on Alaskan acreage and interest charges on 88’s debt facility as well as being ploughed into “new venture opportunities”.

Investors bought new stock in the company at 1.25 cents a share, or the equivalent of 0.7p.

88 was off 5% at 0.67p in early afternoon trading.

Quick facts: 88 Energy Ltd

Price: 0.759 GBX

AIM:88E
Market: AIM
Market Cap: £52.15 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of 88 Energy Ltd named herein, including the promotion by the Company of 88 Energy Ltd in any Content on the Site, the Company receives from said...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Investor update: ANGLE PLC sees head and neck cancer potential for its...

Headlines from the Proactive UK newsroom. ANGLE PLC (LON:AGL,OTCQX:ANPCY) says a review of its ground-breaking liquid biopsy has identified advantages to using the technology when treating head and neck cancer patients. The Parsortix system detects the tell-tale signs of cancer in the form of...

on 13/9/19

2 min read